GMMA as an Alternative Carrier for a Glycoconjugate Vaccine against Group A <i>Streptococcus</i>

Group A <i>Streptococcus</i> (GAS) causes about 500,000 annual deaths globally, and no vaccines are currently available. The Group A Carbohydrate (GAC), conserved across all GAS serotypes, conjugated to an appropriate carrier protein, represents a promising vaccine candidate. Here, we explored the p...

Descripción completa

Detalles Bibliográficos

Autores principales:	Elena Palmieri, Zoltán Kis, James Ozanne, Roberta Di Benedetto, Beatrice Ricchetti, Luisa Massai, Martina Carducci, Davide Oldrini, Gianmarco Gasperini, Maria Grazia Aruta, Omar Rossi, Cleo Kontoravdi, Nilay Shah, Fatme Mawas, Francesca Micoli
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2022-06-01
Colección:	Vaccines
Materias:	Group A <i>Streptococcus</i> GMMA glycoconjugate Group A Carbohydrate
Acceso en línea:	https://www.mdpi.com/2076-393X/10/7/1034
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!